Painfully awkward: Duplicate anesthesiology study retracted

A study that compared drugs used to reverse the effects of relaxants for surgery has been retracted because the majority of the results were already published. The study, “Comparison of sugammadex and pyridostigmine bromide for reversal of rocuronium-induced neuromuscular blockade in short-term pediatric surgery,” appeared in the journal Medicine in February 2020. The work found … Continue reading Painfully awkward: Duplicate anesthesiology study retracted

“Consistently unsurprised”: Nigerian vaccine study with no Nigerian authors retracted

Last month, PLOS ONE published a paper reporting on a trial to improve the uptake of the measles vaccine in Nigeria. The researchers were affiliated with IDinsight, a San Francisco-based “global advisory, data analytics, and research organization that helps development leaders maximize their social impact.” San Francisco is about 7,800 miles from Lagos, and the … Continue reading “Consistently unsurprised”: Nigerian vaccine study with no Nigerian authors retracted

And then there were six: three more retractions for Japanese anesthesiologist

Earlier this month, we reported on the retraction of two papers by a Japanese anesthesiologist for unreliable data. At the time, we noted that the case of Hironobu Ueshima bore watching, given his publication total runs to about 170. [See an update on this story.] The two retractions earlier this month came after an earlier … Continue reading And then there were six: three more retractions for Japanese anesthesiologist

Tortuous and torturous: Why publishing a critical letter to the editor is so difficult

Often, when confronted with allegations of errors in papers they have published, journal editors encourage researchers to submit letters to the editor. Based on what we hear from such letter writers, however, the journals don’t make publication an easy process. Here’s one such story from a group at Indiana University: Luis M. Mestre, Stephanie L. … Continue reading Tortuous and torturous: Why publishing a critical letter to the editor is so difficult

“Honest errors happen in science:” JAMA journal retracts paper on antidepressants

A review of scores of studies on antidepressants has been retracted because it used an incorrect analysis. The original paper, published in JAMA Psychiatry on February 19, 2020, looked at individual differences in patients taking antidepressants and concluded that there were significant differences beyond the placebo effect or the data’s statistical noise. The paper earned … Continue reading “Honest errors happen in science:” JAMA journal retracts paper on antidepressants

NEJM, Lancet place expressions of concern on controversial studies of drugs for COVID-19

[See update on this story.] As controversy swirls around two papers that used data from Surgisphere, the New England Journal of Medicine and The Lancet have placed expression of concerns on the relevant papers. Here’s the NEJM expression of concern:

‘Patterns in the data have led to questions’: Ob-gyns lose another paper

A group of OB/GYNs in the Middle East with a history of testing the patience of editors has lost a paper — and received in expression of concern for another — over concerns about the validity of their data.  The articles appeared in the BJOG, a Wiley publication. Both were led by Mohammad Maher, who … Continue reading ‘Patterns in the data have led to questions’: Ob-gyns lose another paper

Retracted coronavirus (COVID-19) papers

We’ve been tracking retractions of papers about COVID-19 as part of our database. Here’s a running list, which will be updated as needed. (For some context on these figures, see this post, our letter in Accountability in Research and the last section of this Nature news article. Also see a note about the terminology regarding … Continue reading Retracted coronavirus (COVID-19) papers

Hydroxychloroquine-COVID-19 study did not meet publishing society’s “expected standard”

The paper that appears to have triggered the Trump administration’s obsession with hydroxychloroquine as a treatment for infection with the novel coronavirus has received a statement of concern from the society that publishes the journal in which the work appeared.  The April 3, 2020, notice, from the International Journal of Antimicrobial Agents, states that the … Continue reading Hydroxychloroquine-COVID-19 study did not meet publishing society’s “expected standard”

Papers that cite Retraction Watch

Over the years, many papers have cited the work of Retraction Watch, whether a blog post, an article we’ve written for another outlet, or our database. Here’s a selection. Know of one we’ve missed? Let us know at [email protected]. Like Retraction Watch? You can make a tax-deductible contribution to support our work, follow us on Twitter, like … Continue reading Papers that cite Retraction Watch